Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Sep 16;11:18519. doi: 10.1038/s41598-021-97220-8

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2021, corrected publication 2021

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

DHF treatment did not improve metabolic function and ER-mitochondria communication. Legend: PACS-2 and VDAC-1 expression in the hippocampus and cortex of Wild Type (WT), Tg26, and DHF treated Tg26 mice (A-P). Immunohistochemical stained sections show PACS-2 and VDAC-1 expressing cells in the hippocampal and cortex regions of the mice brains. 3 WT mice, 3 Tg26 mice, and 4 TG + DHF mice were used. A, B, C, E, F, G, I, J, K, M, N, and O are 400 × magnification pictures of the hippocampus and cortex regions of the mice. (D) Quantification of PACS-2 expressing cells in the hippocampus: p < 0.001, WT versus Tg; p > 0.05, Tg versus Tg + DHF. (H) Quantification of PACS-2 expressing cells in cortex: p < 0.001, WT versus Tg; p > 0.05, Tg versus Tg + DHF. (L) Quantification of VDAC-1 expressing cells in the hippocampus: p < 0.001, WT versus Tg; p > 0.05, Tg versus Tg + DHF. (P) Quantification of VDAC-1 expressing cells in cortex: p < 0.001, WT versus Tg; p < 0.05, Tg versus Tg + DHF. The total numbers of hippocampal fields analyzed (WT, Tg26, TG + DHF) for each antibody were PACS-2 (62, 110, 112), VDAC-1 (64, 119, 124). The total numbers of cortex fields analyzed (WT, Tg26, TG + DHF) for each antibody were PACS-2 (15, 10, 20), VDAC-1 (15, 15, 20). One Way ANOVA with a Bonferroni's Multiple Comparison post-test. Scale bar, 100 μm.